Urodynamic Evaluation in Patients After Spinal Cord Injury
NCT ID: NCT04231474
Last Updated: 2020-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2 participants
OBSERVATIONAL
2020-01-20
2020-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Neurogenic Detrusor Overactivity: Early Versus Late Pudendal Nerve Stimulation in Spinal Cord Injury (SCI) Patients
NCT01043848
Urodynamics of Suprasacral Spinal Cord Injury Patients
NCT04642170
Pediatric Locomotor Training Bladder Study
NCT03559036
Recovery of Bladder and Sexual Function After Spinal Cord Injury
NCT03036527
Neuro-urological Outcome After Spinal Cord Injury
NCT01297660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Demographic and clinical features of the patients
Number of patients Time from injury to hospitalization Time from injury to urodynamic evaluation Duration of hospitalization
Urodynamic testing
All data were obtained using the MMS Alfa 4T by the same urologist with use of an 8 Charr catheter.
Comparison of urodynamic outcomes
Treatment options in patients with level SCI : cervical, thoracical and lumbar spinal cord injury
Urodynamic testing
All data were obtained using the MMS Alfa 4T by the same urologist with use of an 8 Charr catheter.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urodynamic testing
All data were obtained using the MMS Alfa 4T by the same urologist with use of an 8 Charr catheter.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the results of the urodynamic testing (conducted by the same urologist) by admission,
* urine culture test by admission.
Exclusion Criteria
* without urodynamic test in medical documentation by admission,
* without urine culture test by admission,
* with symptomatic urinary tract infection in urodynamic test
30 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poznan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ewa Chlebus
lek.Ewa Chlebuś, Department of Rehabilitation and Physiotherapy Rehabilitation
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Przemysław Lisiński, MPhD
Role: STUDY_DIRECTOR
Clinic Rehabilitation, University of Medical Sciences in Poznań
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Rehabilitation and Physiotherapy Rehabilitation,
Poznan, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
111/19
Identifier Type: OTHER
Identifier Source: secondary_id
1/2019CReh
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.